Sage Therapeutics Inc. is a biopharmaceutical company that focuses on developing novel medicines to treat life-threatening central nervous system disorders. Their unique approach and dedication to innovation have resulted in promising developments in the fields of depression, postpartum depression, and bipolar disorder. With a strong pipeline and a commitment to improving patient lives, Sage Therapeutics continues to make strides in the world of neuroscience.
